Skip to content
Clinical Trial Events
BIO-Europe 2026

Talk Presenting Companies (Theatre B) track

Drug Discovery and Development: Medicus Pharma Ltd

Mon, Nov 9, 2026 · 9:15–9:30 AM CET Koelnmesse

About this session

Medicus Pharma Ltd. (NASDAQ:MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutic assets designed to transform the standard of care. The company is actively engaged in multiple countries spread over three continents.Our strategy is to advance select programs through Phase 2 proof-of-concept and pursue licensing or strategic partnerships with established pharmaceutical companies that are best positioned to conduct late-stage development and commercialization.

Speaker

  • Faisal Mehmud

    Chief Medical Officer · Medicus Pharma Ltd

    Speaker